JPM
JPMorgan Chase & Co.
$356.59
▲ 0.1%Updated Aug 7, 11:30 AM ET
JPM at a glance — five pillars scored 0–100 from real filed financials.
Overall: Favorable · 69/100. A wider, greener shape means more pillars look healthy. Dividends scores 0 when a company pays none — that is a choice, not a flaw.
▲ Up 18.7% over the last 12 months
Market Cap
$896.22B
P/E
16.18x
Forward P/E (est.)
15.81x
ROE
16.3%
Revenue Growth
109.0%
EPS Growth
2.4%
Profit Margin
33.3%
FCF Yield
5.7%
Debt / Equity
2.55x
ROIC
—
Interest Coverage
—
Current Ratio
—
Dividend Yield
1.9%
Implied Growth (rev. DCF)
—
Rating Score
69/100
JPMorgan is the premier U.S. money-center bank, with diversified earnings across consumer banking, markets, and asset management and a reputation as a best-in-class operator. Like all banks, its earnings are inherently tied to credit cycles and interest-rate conditions.
Institutional-style technical read — sample, educational only
Uptrend — price ($356.59) is above the 50-day ($312.61) and 200-day ($308.49) averages.
Setup type
Trend-continuation swing
Holding time
1–6 weeks
Risk level
Medium
Risk / reward
1 : 0.4
Trade levels
Entry zone
$346.74 – $356.59
Stop loss
$300.33
Target 1
$371.37
Target 2
$385.33
Target 3
$401.75
Position sizing: Scale in; risk ≤ 1% of capital, half-size to start.
Technical analysis
RSI(14) is firm (68); the MACD histogram is positive (upward momentum). Uptrend — price ($356.59) is above the 50-day ($312.61) and 200-day ($308.49) averages. ATR(14) is $8.21 (~2.3% of price), which sets the stop distance. Recent support sits near $304.44 and resistance near $343.45; the 52-week range is $279.10–$343.45.
Fundamental analysis
Revenue is growing at 109.0%, net margin near 33.3%, ROE roughly 16.3%; shares trade at 16x earnings. Quality score: 69/100.
Options flow
Live options-flow data needs a paid feed, so it isn't shown. For realized volatility, ATR of $8.21 (~2.3%/day) is the range to size stops and any option strikes around.
Volume analysis
The latest session traded 0.8× the 20-day average volume — roughly in line with normal activity.
Catalysts
The next quarterly earnings report is the main near-term catalyst. Technically, watch for a break and hold above $343.45 or a loss of $304.44.
Bullish scenario
Scale, funding advantages, and a 'fortress balance sheet' lead the sector.
Bearish scenario
Earnings are sensitive to credit cycles and net-interest-margin swings.
Invalidation
A daily close below $300.33 invalidates this setup read.
Probability-based scenario using sample data — not a recommendation or a guarantee of profit. Prioritize capital preservation, use stops, and size positions for risk. Past performance does not predict future results.
Technical analysis reads price and volume to judge momentum and timing. It complements the fundamentals above — it does not replace them. Here is what JPM's chart says today, with each tool explained.
Trend — moving averages. A moving average is the average closing price over a window, which smooths out daily noise. JPM trades near $356.59, above its 50-day average ($312.61) and 200-day average ($308.49). Price above both averages, with the shorter one above the longer, is the textbook definition of an uptrend — momentum favours buyers.
Momentum — RSI. The Relative Strength Index runs 0–100 and measures how strong recent gains are versus losses. Above 70 is "overbought", below 30 "oversold". At 68 it is in neutral territory — neither stretched nor washed out.
MACD. MACD compares two moving averages to flag shifts in momentum. Its histogram is currently positive — short-term momentum is improving.
Volatility — ATR. Average True Range is the typical daily move. JPM's is $8.21 (~2.3% of price), so swings of about that size each day are normal — handy for setting a stop that isn't too tight.
Support & resistance. Over the last month JPM found buyers near $304.44 (support) and sellers near $343.45 (resistance); its 52-week range is $279.10–$343.45. A decisive break beyond either edge often marks the next move.
Volume. The latest session traded 0.8× the 20-day average — about normal. Rising volume on up-days suggests real buying; on down-days, real selling.
Educational information to help you read a chart — not a recommendation or a forecast. It updates daily as the price and indicators change.
4Y CAGR
10.7%
Revenue grew from $96.57B in 2016 to $182.45B in 2025, a 7.3% CAGR. The most recent year grew about 109.0% year over year, a healthy pace pointing to durable demand.
Gross Margin
—
Operating Margin
—
Net Margin
31.3%
ROE
16.3%
Gross margin runs near 55.0% with operating margin around 41.2% and net margin near 33.3%. Return on equity of roughly 16.3% indicates moderate capital efficiency, and the margin profile has trended high and stable over the period shown.
Total Debt
$269.93B
Net Debt
-$8.86B
Net cash position
Net Debt / EBITDA
—
Debt / Equity
2.55x
Interest-bearing debt is about 35.0% of market capitalization and the debt-to-equity ratio is roughly 2.55x. Leverage is elevated, which is typical for this business model but worth monitoring.
Operating CF
-$147.78B
Free Cash Flow
-$147.78B
FCF Margin
-81.0%
Operating cash flow comfortably exceeds reported net income, and free cash flow yield is around 5.7%. Cash generation is robust and supports buybacks, dividends, and reinvestment.
Can the payout survive a bad year? Scored from filed cash flow, earnings coverage, and the raise/cut record.
Coverage is weak, the payout was cut recently, or it's being financed rather than earned — treat the current yield as fragile.
Dividend yield
1.9%
Per share (latest FY)
$5.80
Total paid (latest FY)
$16.63B
History on record
10 years
free cash flow was negative in the latest year — the dividend is being financed
29% of net income paid out
total dividends increased 2 years in a row
no cuts in the last 10 years on record
Coverage uses the latest fiscal year as filed with the SEC; the streak counts total dollars paid (per-share figures can carry split artifacts). Educational information, not income advice.
P/E
16.18x
P/S
3.47x
P/B
2.61x
EV / EBITDA
12x
Shares trade at roughly 16x trailing earnings (13x forward), 3.5x sales, and 12x EV/EBITDA. That is a reasonable-to-cheap multiple relative to the broader market. Our internal rating is Favorable.
Where JPM sits versus its Financials sector peers in the S&P 500.
Bands show the middle half (25th–75th percentile) of the 141 Financials companies in the S&P 500 — the peer-relative anchor professional comps analysis uses. Context only — not investment advice.
How JPM stacks up against its Financials peers — valuation, profitability, and growth versus the sector median.
In the Financials sector (289 S&P 500 companies), JPM ranks #45 of 289 by our overall rating. It trades at roughly in line versus the sector on earnings (16.2x P/E vs. 15.8x median) with a higher return on equity (16.3% vs. 13.6%) and faster revenue growth (109.0% vs. 15.9%).
P/E vs sector
16.2x
median 15.8x
ROE vs sector
16.3%
median 13.6%
Growth vs sector
109.0%
median 15.9%
Sector rank
#45
of 289 by rating
Valuation vs. quality map
The sweet spot is upper-left: more profitable (higher ROE) for a lower P/E. Dashed lines mark the sector median.
Peers are the closest Financials companies by sub-industry and size. Sector median is across all 289 S&P 500 names in the sector. Educational, not a recommendation.
Project revenue → earnings → price. Edit the assumptions to build your own case.
2030 price target (Base Case)
$0.00 – $0.00
vs. $356.59 today · expected CAGR 32% – 45%
| Metric | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| Revenue | $264.55B | $383.59B | $556.21B | $806.51B | $1.17T |
| Net income | $82.01B | $118.91B | $172.43B | $250.02B | $362.53B |
| EPS | $32.63 | $47.31 | $68.61 | $99.48 | $144.24 |
| Share price (low) | $326.30 | $473.14 | $686.05 | $994.78 | $1,442.43 |
| Share price (high) | $522.09 | $757.03 | $1,097.69 | $1,591.65 | $2,307.89 |
| CAGR (low–high) | -8% / 46% | 15% / 46% | 24% / 45% | 29% / 45% | 32% / 45% |
Educational model on sample fundamentals — not a forecast or investment advice. Outputs are only as good as your assumptions.
- Scale, funding advantages, and a 'fortress balance sheet' lead the sector.
- Diversified fee and net-interest income across cycles.
- Strong returns on equity and consistent capital returns.
- Earnings are sensitive to credit cycles and net-interest-margin swings.
- Heavy regulation and capital requirements cap upside.
- Banking is cyclical — loan losses spike exactly when the economy weakens.
- Credit losses in a recession.
- Interest-rate and yield-curve shifts.
- Regulatory capital changes.
JPMorgan is arguably the best-run large bank in the world, but it remains a cyclical, rate-sensitive business — quality deserves a premium, yet the sector's economics put a natural ceiling on long-run compounding.
Analyst Ratings
What 30 Wall Street analysts covering JPM recommend (August 2026). Consensus is a useful sanity check — not a substitute for your own homework.
Latest SEC Filings
JPM's most recent filings, straight from SEC EDGAR. Annual and quarterly reports are the deep dives; 8-Ks flag material events the moment they happen.
In the Idea Lab
JPM — frequently asked questions
Is JPM a good stock to buy?
We don't give buy or sell advice. Our model rates JPMorgan Chase & Co. Favorable (69/100) based on its growth, profitability, financial health, and valuation — use that as a research starting point and make your own decision.
What is JPM's rating on The Stocks School?
JPMorgan Chase & Co. currently scores 69/100 (Favorable) on our transparent model, which weighs real fundamentals: growth, margins, returns on capital, balance-sheet strength, and valuation.
How our ratings work →Where does JPM's data come from?
Live price data plus real fundamentals and 5-year financials pulled directly from JPMorgan Chase & Co.'s SEC filings — refreshed automatically, not hand-entered.
How is the 5-year projection for JPM calculated?
It's a scenario model: it grows revenue at an assumed rate, applies a profit margin and a valuation multiple, and shows the resulting share-price range. The assumptions are yours to change — it's a tool for thinking, not a prediction.
Is this JPM analysis financial advice?
No. Everything on this page is educational research, not financial advice or a recommendation to buy or sell JPM. Always do your own research and consider a licensed professional.
Data notice. Fundamentals and financial statements are sourced from company filings (SEC EDGAR) and market-data providers; prices and market caps refresh on trading days and may be delayed. Ratings, projections, technical signals, and written summaries are model- or rule-generated for education and may simplify or lag the latest filings.
Not advice. Nothing on this page is investment advice or a recommendation to buy, hold, or sell any security. Do your own research and consult a licensed financial professional before investing.